Medical devices are becoming the latest equipment to utilize the Internet to collect data and to send alerts. Here ‘smart inhalers’ are leading the way, with the first commercial units expected within a year. We take a look at the latest developments.
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data suggests this is now the norm rather than the exception.
Democratic presidential candidate Bernie Sanders campaign received a maximum individual donation of $2,700 from Mark Shkreli, Turing Pharmaceutical CEO, who's been branded as the Big Pharma "poster boy" by a Sander's staffer.
The latest figures for the amount of money spent by the pharmaceutical industry on the medical profession for the U.K. has been revealed — £41 million ($60 million). This is dwarfed by the amount spent in the U.S.
It has been a mixed week for the pharmaceutical sector in terms of drug development, with success for Novartis and disappointing news for Boehringer and Vitae Pharma. Digital Journal reports on the latest news.
The Federal Court of Australia has rejected an appeal of a ruling that allows companies to patent isolated human genes. This reignites the debate: who owns your genes - you or the company that extracts them?
Japan's biggest pharmaceutical company has been hit with a $6 billion penalty for concealing cancer risks associated with its Actos diabetes drug while Eli Lilly and Co, Takeda's co-defendant in the case, was ordered to pay $3 billion in punitive damages.
The pharmaceutical company Mylan has voluntarily recalled three types of painkiller tablets due to the risk that the tablets are more potent than the label indicates. The risk is that consumers could overdose.
Following the reports about the contaminated sterile medicines produced by the NEEC pharmacy, the State of Massachusetts has closed three more compounding pharmacies due to concerns over risks to patients.